On November 11, 2025, Jones Trading’s Soumit Roy reiterated his “Buy” rating on Janux Therapeutics, Inc. (NASDAQ:JANX), which reflects promising developments in the company’s prostate cancer program.
The CNPV program now includes 15 therapies, focusing on critical public health and national security priorities like obesity, cancer, and drug-resistant tuberculosis. Accelerated review timelines ...
Offers a safe learning environment through simulated trading accounts and Arabic support Financial trading is an exciting and challenging field that offers countless opportunities for learning, but it ...
The Public API allows you to program your trading and is completely free to use. Learn how to apply for access, generate your tokens, and implement our code snippets to automate your custom trading ...
Prairie View is launching its Student Sickle Cell Warrior Project, a first-of-its-kind program designed to support college students living with SCD. According to the Red Cross, sickle cell disease ...
Joby Aviation Inc (NYSE:JOBY) shares are trading higher Friday morning after the company announced its participation in the White House’s new eVTOL Integration Pilot Program. What To Know: The ...
Vietnam has officially kicked off a five-year pilot program for regulated cryptocurrency trading platforms aimed at capitalizing on the growing digital asset market in the country. According to a ...
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...
In a city that saw a 136% increase in minors arrested with a gun from 2018 to 2024, a unique effort is underway to empower some of those young people to put their lives on a new path. The New York ...
Robinhood is developing a blockchain-based program to allow traders in Europe access to U.S. financial assets, two people familiar with the matter told Bloomberg. Tokenized assets have become a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results